Bristol-Myers Squibb

YTD

ALL

Trade Bristol-Myers Squibb 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About BMY

Bristol Myers Squibb Co. engages in the discovery, development, licensing, manufacture, marketing, distribution, and sale of biopharmaceutical products. It offers small molecules, products produced from biological processes called biologics, and chimeric antigen receptor (CAR-T) cell therapies.

CEO

Christopher S. Boerner

CEOChristopher S. Boerner

Employees

32,500

Employees32,500

Headquarters

Princeton, New Jersey

HeadquartersPrinceton, New Jersey

Founded

1933

Founded1933

Employees

32,500

Employees32,500

BMY Key Statistics

Market cap

114.85B

Market cap114.85B

Price-Earnings ratio

15.88

Price-Earnings ratio15.88

Dividend yield

4.42%

Dividend yield4.42%

Average volume

11.42M

Average volume11.42M

High today

$56.90

High today$56.90

Low today

$55.57

Low today$55.57

Open price

$56.49

Open price$56.49

Volume

5.69M

Volume5.69M

52 Week high

$62.89

52 Week high$62.89

52 Week low

$42.52

52 Week low$42.52

Stock Snapshot

Bristol-Myers Squibb(BMY) stock is priced at $56.24, giving the company a market capitalization of 114.85B. It carries a P/E multiple of 15.88 and pays a dividend yield of 4.4%.

During the trading session on 2026-05-07, Bristol-Myers Squibb(BMY) shares reached a daily high of $56.90 and a low of $55.57. At a current price of $56.24, the stock is +1.2% higher than the low and still -1.2% under the high.

Trading activity shows a volume of 5.69M, compared to an average daily volume of 11.42M.

The stock's 52-week range extends from a low of $42.52 to a high of $62.89.

BMY News

TipRanks 3d

Analyst Maintains Hold on Bristol-Myers Squibb, Keeps Price Target Unchanged at $61 Amid Pipeline Uncertainty

Analyst Asad Haider from Goldman Sachs maintained a Hold rating on Bristol-Myers Squibb and keeping the price target at $61.00. Claim 55% Off TipRanks Unlock he...

Simply Wall St 4d

A Look At Bristol Myers Squibb Valuation After Its Q1 2026 Earnings Beat And Reaffirmed Guidance

Bristol-Myers Squibb (BMY) reported first quarter 2026 results that came in ahead of analyst expectations, with double digit growth from its newer drugs and a r...

Analyst ratings

58%

of 31 ratings

Buy

38.7%

Hold

58.1%

Sell

3.2%

People also own

Based on the portfolios of people who own BMY. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.